Summary
The replication rates and pathogenicities of the SA 14 parent and SA 14-14-2 vaccine strains of Japanese encephalitis (JE) virus in neurons of the mouse brain following intracerebral inoculation were compared. All the mice inoculated with the SA 14 parent strain died within one week postinoculation (p.i.), whereas all the mice inoculated with the SA 14-14-2 vaccine strains survived without showing any signs of central nervous system (CNS) involvement. The virus titers of the mouse brains inoculated with the SA 14 strain reached progressively higher levels until day 5 when the animals died. On the other hand, the virus titers of the mouse brains inoculated with the SA 14-14-2 strain persisted at low levels for several days and could not be detected after 10 days. In the routine electron microscopical study, a majority of neurons in the mouse brains inoculated with the SA 14 strain contained virions and showed characteristic cytopathological changes in connection with viral replication. In the brains inoculated with the SA 14-14-2 strain, however, we failed to find neurons containing virions or showing characteristic cytopathological changes. In the alkaline phosphatase immunostaining of paraffin-embedded sections, a majority of neurons in the brains of mice inoculated with the SA 14 strain stained positively on day 5 p.i., but only a small number of neurons in scattered small foci stained positively in the brains inoculated with the SA 14-14-2 strain. The immunogold staining of Vibratome sections also revealed the identical patterns; moreover, electron microscopical examination of the immunopositive foci of the brain inoculated with the vaccine strain revealed neurons that contained virions in dilated cisternae of rough endoplasmic reticulum (RER), indicating that the SA 14-14-2 strain also replicated, albeit poorly, in neurons. The present results showed that upon intracerebral inoculation into mice the SA 14 parent strain of JE virus grew vigorously in a large number of neurons, killing the animals, while the SA 14-14-2 vaccine strain grew poorly only in a small number of neurons without causing mortality. Possible mechanisms involved in the alteration of pathogenicity between the SA 14 parent virus and the SA 14-14-2 vaccine virus are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cecilia D, Gadakari DA, Kedarnath N, Ghosh SN (1988) Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain. J Gen Virol 69: 2741–2747
Downs MB, White JD (1989) Localization of viral antigens: immunogold labeling and silver enhancement of Vibratome tissue sections. EMSA Bull 19: 74–77
Eckels KH, Brandt WE, Harrison VR, McCown JM, Russell PK (1976) Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun 14: 1221–1227
Eckels KH, Yu YX, Dubois DR, Marchette NJ, Trent DW, Johnson AJ (1988) Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6: 513–518
Hall WC, Crowell TP, Watts DM, Barros VLR, Kruger H, Pinheiro F, Peters CJ (1991) Demonstration of yellow fever and dengue antigens in formalin-fixed paraffinembedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 45: 408–417
Hase T, Summer PL, Eckels KH, Baze WB (1987) Maturation process of Japanese encephalitis virus in cultured mosquito cells in vitro and mouse brain cells in vivo. Arch Virol 96: 135–151
Hase T, Summers PL, Eckels KH (1989) Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch Virol 104: 129–143
Hase T, Summers PL, Cohen WH (1989) A comparative study of entry modes into C6/36 cells by Semliki Forest and Japanese encephalitis virus. Arch Virol 108: 101–114
Hase T, Summers PL, Eckels KH, Putnak JR (1980) Morphogenesis of flaviviruses. In: Harris JR (ed) Virally infected cells. Plenum, New York, pp 275–305 (Subcellular biochemistry, vol 15)
Hase T, Summers PL, Dubois DR (1990) Ultrastructural changes of mouse brain neurons infected with Japanese encephalitis virus. Int J Exp Pathol 71: 493–505
Hase T, Dubois DR, Summers PL (1990) Comparative study of mouse brains infected with Japanese encephalitis virus by intracerebral or intraperitoneal inoculation. Int J Exp Pathol 71: 857–869
Hase T, Summers PL, Ray P (1990) Entry and replication of Japanese encephalitis virus in cultured neurogenic cells. J Virol Methods 30: 205–214
Holzmann H, Heinz FX, Mandl CW, Guirakhoo F, Kunz C (1990) Single amino acid substitution in envelope protein E of tickborne encephalitis virus leads to attenuation in the mouse model. J Virol 64: 5156–5159
Kimura-Kuroda J, Yasui K (1983) Topographical analysis of antigenic determinants on envelope glycoprotein V 3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol 45: 124–132
Kimura-Kuroda J, Yasui K (1986) Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J Gen Virol 67: 2663–2672
Konishi E, Pincus S, Fonseca BAL, Shope RE, Paoletti E, Mason PW (1991) Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 185: 401–410
Leary K, Blair CD (1980) Sequential events in the morphogenesis of Japanese encephalitis virus. J Ultrastruct Res 72: 123–129
Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL (1989) Molecular chracterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70: 2037–2049
Mason PW, Pincus S, Fournier MJ, Mason OL, Shope RE, Paoletti E (1991) Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180: 294–305
McDowell EM, Trump BF (1976) Histopathologic fixatives suitable for diagnostic and electron microscopy. Arch Pathol Lab Med 100: 405–414
Nitayaphan S, Grant JA, Chang GJ, Trent DW (1990) Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology 177: 541–552
Summers PL, Cohen WH, Ruiz MM, Hase T, Eckels KH (1989) Flavivirus can mediate fusion from without in Aedes albopictus mosquito cell cultures. Virus Res 12: 383–392
Takegami T, Miyamoto H, Nakamura H, Yasui K (1982) Biological activities of the structural proteins of Japanese encephalitis virus. Acta Virol 26: 312–320
Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K (1990) Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express preM and E glycoproteins of Japanese encephalitis virus. J Virol 64: 2788–2795
Yu YX, Wu PF, Ao J, Liu LH, Li HM (1981) Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. I. Some biological characteristics of SA 14-14-2 mutant. Chin J Microbiol Immunol 1: 77–83
Yu YX, Zahng GM, Guo YP, Ao J, Li HM (1988) Safety of a live attenuated Japanese encephalitis virus vaccine (SA 14-14-2) for children. Am J Trop Med Hyg 39: 214–217
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hase, T., Dubois, D.R., Summers, P.L. et al. Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Archives of Virology 130, 131–143 (1993). https://doi.org/10.1007/BF01319002
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01319002